{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:10Z","timestamp":1789564210470,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"DOI":"10.7759\/cureus.116345","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:51:07Z","timestamp":1789563067000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Outcomes of Beta-Blockers vs Non-Dihydropyridine Calcium Channel Blockers in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Salman A","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansuor","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad F","family":"Aljuadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Moeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifah K","family":"Albaiahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem A","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa N","family":"Alwabisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrab K","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan S","family":"Alquthami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanoud T","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaima A","family":"Almaadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S","family":"Metwaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101515","article-title":"Effects of calcium channel blockers in patients with heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis","volume":"55","author":"Fukuta H","year":"2024","unstructured":"Fukuta H, Goto T, Kamiya T. Effects of calcium channel blockers in patients with heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2024, 55:101515. 10.1016\/j.ijcha.2024.101515","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.126.26801","article-title":"Calcium channel blockade versus \u03b2-blockade for hypertension in heart failure with preserved ejection fraction: a randomized crossover trial","volume":"83","author":"Cohen JB","year":"2026","unstructured":"Cohen JB, Hossain A, Chittams J, et al.. Calcium channel blockade versus \u03b2-blockade for hypertension in heart failure with preserved ejection fraction: a randomized crossover trial. Hypertension. 2026, 83:e26801. 10.1161\/HYPERTENSIONAHA.126.26801","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07334-y","article-title":"An updated review on the role of non-dihydropyridine calcium channel blockers and beta-blockers in atrial fibrillation and acute decompensated heart failure: evidence and gaps","volume":"37","author":"Triska J","year":"2023","unstructured":"Triska J, Tamargo J, Bozkurt B, Elkayam U, Taylor A, Birnbaum Y. An updated review on the role of non-dihydropyridine calcium channel blockers and beta-blockers in atrial fibrillation and acute decompensated heart failure: evidence and gaps. Cardiovasc Drugs Ther. 2023, 37:1205-23. 10.1007\/s10557-022-07334-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3329\/cardio.v17i1.80000","article-title":"Beta-blockers in heart failure with preserved ejection fraction and comorbidities","volume":"17","author":"Majumder AA","year":"2024","unstructured":"Majumder AA. Beta-blockers in heart failure with preserved ejection fraction and comorbidities. Cardiovasc J. 2024, 17:1-4. 10.3329\/cardio.v17i1.80000","journal-title":"Cardiovasc J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12091","article-title":"Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness","volume":"20","author":"Scheuermeyer FX","year":"2013","unstructured":"Scheuermeyer FX, Grafstein E, Stenstrom R, et al.. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness. Acad Emerg Med. 2013, 20:222-30. 10.1111\/acem.12091","journal-title":"Acad Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht429","article-title":"Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation","volume":"35","author":"Ulimoen SR","year":"2014","unstructured":"Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Heart J. 2014, 35:517-24. 10.1093\/eurheartj\/eht429","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or Flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm C","year":"2015","unstructured":"Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J, Marshall J. Diltiazem vs. metoprolol in the management of atrial fibrillation or Flutter with rapid ventricular rate in the emergency department. J Emerg Med. 2015, 49:175-82. 10.1016\/j.jemermed.2015.01.014","journal-title":"J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160126","article-title":"Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department","volume":"73","author":"Hines MC","year":"2016","unstructured":"Hines MC, Reed BN, Ivaturi V, Bontempo LJ, Bond MC, Hayes BD. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department. Am J Health Syst Pharm. 2016, 73:2068-76. 10.2146\/ajhp160126","journal-title":"Am J Health Syst Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.073","article-title":"Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: metoprolol vs. diltiazem","volume":"40","author":"Hargrove KL","year":"2021","unstructured":"Hargrove KL, Robinson EE, Lusk KA, Hughes DW, Neff LA, Fowler AL. Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: metoprolol vs. diltiazem. Am J Emerg Med. 2021, 40:15-9. 10.1016\/j.ajem.2020.11.073","journal-title":"Am J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan C","year":"2005","unstructured":"Demircan C, Cikriklar HI, Engindeniz Z, et al.. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg Med J. 2005, 22:411-4. 10.1136\/emj.2003.012047","journal-title":"Emerg Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.06.117","article-title":"Treating rapid atrial fibrillation in acute decompensated heart failure: metoprolol and diltiazem are equally safe, yet metoprolol increases conversion to sinus rhythm","volume":"20","author":"Katchi F","year":"2014","unstructured":"Katchi F, Nagabandi S, Shuster J, Novak E, Joseph S. Treating rapid atrial fibrillation in acute decompensated heart failure: metoprolol and diltiazem are equally safe, yet metoprolol increases conversion to sinus rhythm. J Card Fail. 2014, 20:41. 10.1016\/j.cardfail.2014.06.117","journal-title":"J Card Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and \u03b2-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson L","year":"2000","unstructured":"Hansson L, Hedner T, Lund-Johansen P, et al.. Randomised trial of effects of calcium antagonists compared with diuretics and \u03b2-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet. 2000, 356:359-65. 10.1016\/s0140-6736(00)02526-5","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth A","year":"2012","unstructured":"Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012, 1:2. 10.1186\/2046-4053-1-2","journal-title":"Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh ML","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012, 22:276-82. 10.11613\/BM.2012.031","journal-title":"Biochem Med (Zagreb)"},{"key":"ref16","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells GA","year":"2014","unstructured":"Wells GA, Shea B, O'Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa; 2014."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336:924-6. 10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"ref18","unstructured":"The R Project for Statistical Computing. (2026). https.\/\/www.R-project.org\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi S","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019, 22:153-60. 10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout J","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014, 14:25. 10.1186\/1471-2288-14-25","journal-title":"BMC Med Res Methodol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315:629-34. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i12.115254","article-title":"Comparison of beta-blockers vs calcium channel blockers in heart failure with preserved ejection fraction","volume":"17","author":"Mansoor M","year":"2025","unstructured":"Mansoor M, Depar FN, Talha HU, et al.. Comparison of beta-blockers vs calcium channel blockers in heart failure with preserved ejection fraction. World J Cardiol. 2025, 17:115254. 10.4330\/wjc.v17.i12.115254","journal-title":"World J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.04.013","article-title":"Association of nondihydropyridine calcium channel blockers versus \u03b2-adrenergic receptor blockers with risk of heart failure hospitalization","volume":"197","author":"Meyer M","year":"2023","unstructured":"Meyer M, Wetmore JB, Weinhandl ED, Roetker NS. Association of nondihydropyridine calcium channel blockers versus \u03b2-adrenergic receptor blockers with risk of heart failure hospitalization. Am J Cardiol. 2023, 197:68-74. 10.1016\/j.amjcard.2023.04.013","journal-title":"Am J Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug BA","year":"2011","unstructured":"Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011, 123:2006-13; discussion 2014. 10.1161\/CIRCULATIONAHA.110.954388","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.08.073","article-title":"Effect of \u03b2-blocker withdrawal on functional capacity in heart\u00a0failure and preserved ejection fraction","volume":"78","author":"Palau P","year":"2021","unstructured":"Palau P, Seller J, Dom\u00ednguez E, et al.. Effect of \u03b2-blocker withdrawal on functional capacity in heart\u00a0failure and preserved ejection fraction. J Am Coll Cardiol. 2021, 78:2042-56. 10.1016\/j.jacc.2021.08.073","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90461-W","article-title":"Ventricular control and exercise performance in chronic atrial fibrillation: effects of diltiazem verapamil","volume":"16","author":"Lundstr\u00f6m T","year":"1990","unstructured":"Lundstr\u00f6m T, Ryd\u00e9n L. Ventricular control and exercise performance in chronic atrial fibrillation: effects of diltiazem verapamil. J Am Coll Cardiol. 1990, 16:86-90. 10.1016\/0735-1097(90)90461-W","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/525441-comparative-outcomes-of-beta-blockers-vs-non-dihydropyridine-calcium-channel-blockers-in-heart-failure-with-preserved-ejection-fraction-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:51:12Z","timestamp":1789563072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/525441-comparative-outcomes-of-beta-blockers-vs-non-dihydropyridine-calcium-channel-blockers-in-heart-failure-with-preserved-ejection-fraction-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.116345","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}